| Identification | Back Directory | [Name]
MFCD00126723 | [CAS]
116850-74-9 | [Synonyms]
KM02894 MFCD00126723 N-methyl-2-(2-thienylcarbonyl)hydrazinecarbothioamide N-Methyl-2-(thiophene-2-carbonyl)hydrazinecarbothioamide N-methyl-2-(thiophen-2-ylcarbonyl)hydrazinecarbothioamide N1-methyl-2-(2-thienylcarbonyl)hydrazine-1-carbothioamide 2-Thiophenecarboxylic acid, 2-[(methylamino)thioxomethyl]hydrazide | [Molecular Formula]
C7H9N3OS2 | [MDL Number]
MFCD00126723 | [MOL File]
116850-74-9.mol | [Molecular Weight]
215.3 |
| Hazard Information | Back Directory | [Uses]
KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research[1]. | [References]
[1] Fazzari J, et.al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380. DOI:10.1038/srep08380 |
|
| Company Name: |
Matrix Scientific
|
| Tel: |
803 788-9494 All other calls |
| Website: |
www.matrixscientific.com |
| Company Name: |
Fluorochem Ltd
|
| Tel: |
(01457) 868921 (4 lines) |
| Website: |
www.fluorochem.co.uk |
|